In this system, HMGN2 reduces the binding of linker histone H1 to chromatin regulatory regions, thereby enhancing STAT5 accessibility to promoter DNA, ultimately leading to increased proliferation of breast cancer cells [54,55]. The gene discussed is HMGN2; the disease is breast carcinoma.